Kansas City Oncology and Hematology Group — Kansas City, Missouri

Kansas City Oncology and Hematology Group is a clinical research site located in Kansas City, Missouri, United States 64131.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Kansas City Oncology and Hematology Group has participated in 11 clinical trials.

Therapeutic areas: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Sponsors: Novartis, Intarcia Therapeutics, Chiron Corporation.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Oncology and Hematology Group?

Kansas City Oncology and Hematology Group has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Oncology and Hematology Group conducted?

Kansas City Oncology and Hematology Group has 11 clinical trials on record. Their work covers Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Is Kansas City Oncology and Hematology Group accredited by Crixeo Health?

Yes — Kansas City Oncology and Hematology Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kansas City Oncology and Hematology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.